| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |